Nuwellis YTD revenue grows 13%, gross margin hits 72%
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Nuwellis, Inc. (NUWE) posted an updated November 2026 investor presentation. It reports YTD 2026 revenue growth of 13% versus the prior-year period and a gross margin of 72%, compared with 59% in the prior year. Cash was $8.3 million as of September 30, 2026, with a stated runway through Q2 2027. Pediatrics represented approximately 46% of YTD 2026 revenue, and the presentation lists 47 leading U.S. children’s hospital accounts.
Nuwellis said it submitted a 510(k) in November 2026 to expand the Aquadex weight indication from >20 kg to >5 kg. Listed target milestones include Zorro-Flow commercialization in Q1 2027, SmartView in H1 2027, Pressure IQ and ClarityPRIME in H2 2027, and multiple filters from Q4 2027 to Q1 2028. ClarityPRIME and Vivian are under development, and ClarityPRIME is not FDA cleared. The presentation describes a potential $4.4 billion U.S. market across its platform and future products; it cautions that forward-looking statements are not guarantees and actual results may differ materially.
How this balance works
Rhea-AI gives every point it takes from this document a weight. Minor counts 1, Moderate 3 and Major 9, so one Major point outweighs several Minor ones. The bar adds up the weights on each side, and when neither side holds more than 65% of the total the balance reads Mixed.
It reads the document as published, with the same rules for every company, and it does not look at what the market expected or at how the stock traded, so a point can be objectively good on a day the stock falls.
Rhea-AI Sentiment measures something else, the tone of the wording.
Positive
- Moderate pointYTD revenue growth reached 13% versus the prior-year period.
- Moderate pointYTD gross margin was 72%, compared with 59% in the prior year.
Negative
- None.
8-K Event Classification
Key Figures
Key Terms
ultrafiltration technical
510(k) regulatory
ECMO medical
CRRT medical
CVVH medical
CVVHD medical
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What financial metrics did NUWE report for YTD 2026?
How much cash did NUWE have, and what runway did it report?
AI-generated analysis. How Rhea-AI works. Not financial advice.























